Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Idexx Laboratories (IDXX)

Idexx Laboratories (IDXX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 32,136,330
  • Shares Outstanding, K 85,055
  • Annual Sales, $ 2,407 M
  • Annual Income, $ 427,720 K
  • 60-Month Beta 0.81
  • Price/Sales 12.91
  • Price/Cash Flow 60.79
  • Price/Book 113.70

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate 1.39
  • Number of Estimates 4
  • High Estimate 1.48
  • Low Estimate 1.34
  • Prior Year 1.24
  • Growth Rate Est. (year over year) +12.10%

Price Performance

See More
Period Period Low Period High Performance
1-Month
347.54 +8.72%
on 09/18/20
407.45 -7.27%
on 09/02/20
-6.10 (-1.59%)
since 08/25/20
3-Month
322.00 +17.34%
on 06/29/20
407.86 -7.36%
on 07/31/20
+50.44 (+15.41%)
since 06/25/20
52-Week
168.65 +124.03%
on 03/23/20
407.86 -7.36%
on 07/31/20
+103.03 (+37.49%)
since 09/25/19

Most Recent Stories

More News
Idexx Labs Up 88.8% Since SmarTrend Uptrend Call (IDXX)

SmarTrend identified an Uptrend for Idexx Labs (NASDAQ:IDXX) on March 25th, 2020 at $212.26. In approximately 5 months, Idexx Labs has returned 88.79% as of today's recent price of $400.71.

IDXX : 377.83 (+3.38%)
Global Escherichia Coli (E. coli) Testing Market Analysis 2020-2025

, /PRNewswire/ -- The report has been added to offering.

IDXX : 377.83 (+3.38%)
LZAGF : 609.3700 (-0.53%)
MRK : 82.93 (-0.26%)
VIVO : 16.50 (+6.38%)
NNLX : 0.0525 (unch)
Should John Hancock Multifactor Mid Cap ETF (JHMM) Be on Your Investing Radar?

Style Box ETF report for JHMM

JHMM : 36.88 (+1.54%)
SNPS : 208.50 (+3.47%)
CDNS : 103.72 (+1.57%)
IDXX : 377.83 (+3.38%)
IJH : 180.94 (+1.36%)
VO : 172.90 (+1.87%)
Idexx (IDXX) Up 2.6% Since Last Earnings Report: Can It Continue?

Idexx (IDXX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

IDXX : 377.83 (+3.38%)
Idexx Labs Falls 1.14% on Heavy Volume: Watch For Potential Rebound

Idexx Labs (NASDAQ:IDXX) traded in a range yesterday that spanned from a low of $377.01 to a high of $383.63. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $379.50...

IDXX : 377.83 (+3.38%)
Shares of IDXX Up 80.5% Since Uptrend Call on Shares

SmarTrend identified an Uptrend for Idexx Labs (NASDAQ:IDXX) on March 25th, 2020 at $212.26. In approximately 5 months, Idexx Labs has returned 80.55% as of today's recent price of $383.22.

IDXX : 377.83 (+3.38%)
IDEXX Laboratories Provides U.S. Companion Animal Market Trends Update

, /PRNewswire/ -- (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, today provided an update on U.S. Companion Animal Market Trends...

IDXX : 377.83 (+3.38%)
IDEXX expands ImageVue digital imaging portfolio, making enhanced radiation safety and superior diagnostic image quality affordable to more veterinarians

IDEXX expands ImageVue digital imaging portfolio, making enhanced radiation safety and superior diagnostic image quality affordable to more veterinarians

IDXX : 377.83 (+3.38%)
IDEXX launches groundbreaking new ProCyte One Hematology Analyzer with dramatically simplified user experience

IDEXX launches groundbreaking new ProCyte One Hematology Analyzer with dramatically simplified user experience

IDXX : 377.83 (+3.38%)
IDEXX Laboratories to Host Virtual Investor Day

, /PRNewswire/ --  (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, will host its 2020 virtual Investor Day on from – .

IDXX : 377.83 (+3.38%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade IDXX with:

Business Summary

IDEXX Laboratories, Inc. is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. IDEXX products enhance the ability of veterinarians to provide advanced medical care, improve staff...

See More

Key Turning Points

2nd Resistance Point 390.42
1st Resistance Point 384.13
Last Price 377.83
1st Support Level 368.06
2nd Support Level 358.28

See More

52-Week High 407.86
Last Price 377.83
Fibonacci 61.8% 316.48
Fibonacci 50% 288.26
Fibonacci 38.2% 260.03
52-Week Low 168.65

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar